Management of infertility in women with endometriosis

Barbara Grzechocinska, Barbara Grzechocińska, Grzechocinska B, Miroslaw Wielgos, Mirosław Wielgoś
Neuro endocrinology letters · 2012 · vol. 33(7) , pp. 674–9 · PMID:23391886 · W125615632
Review OA: closed CC0 ⤵ 5 in-corpus citations
View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-10 ⓘ

Laparoscopic ablation of endometriosis improves fertility in minimal-to-mild cases, while hormonal suppression alone does not; treatment strategies for endometriosis-associated infertility vary by stage and patient age, with IVF being recommended for more severe cases or older patients.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Although there is confirmed an association between endometriosis and infertility, precise standards of managements have not yet been established. Ablation of endometriotic lesions plus adhesiolysis in minimal to mild endometriosis is more effective than diagnostic laparoscopy alone in improving fertility. Suppression of ovarian function and hormonal treatment alone are not effective in improving fertility. In women with stage I/II endometriosis associated infertility, expectant management or IUI after laparoscopy can be considered for younger patients. Women 35 years of age or older should be treated with IUI or IVF-ET. IVF pregnancy rate are lower in women with endometriosis than in those with tubal infertility. For women with stage III/IV endometriosis who fail to conceive following conservative surgery IVF-ET is should be offered.

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

MeSH descriptors

Endometriosis Endometriosis Infertility, Female Infertility, Female Reproductive Medicine Endometriosis Endometriosis Female Female Humans Humans Infertility, Female Infertility, Female Pregnancy Pregnancy Prognosis Prognosis Reproductive Medicine Reproductive Medicine

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

Cited by (5)

Source provenance

europepmc
last seen: 2026-10-16T06:09:50.462052+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:11:31.379484+00:00
License: CC0 · commercial use OK